Shoden Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Company Age 17 Year, 7 Days
- Open Charges ₹ 0.90 M
About Shoden Pharmaceuticals
Shoden Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 January 2008 and has a history of 17 years. Its registered office is in Kozhikode, Kerala, India.
The Company is engaged in the Home Appliances Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.00.
The company currently has active open charges totaling ₹0.90 M.
Sreekanth Mana, Madhu Palanchery, Manoj Poyil, and One other member serve as directors at the Company.
Company Details
-
Location
Kozhikode, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U52310KL2008PTC021743
-
Company No.
021743
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Jan 2008
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Shoden Pharmaceuticals?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sreekanth Mana | Managing Director | 25-Jan-2008 | Current |
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Madhu Palanchery | Director | 25-Jan-2008 | Current |
Manoj Poyil | Director | 25-Jan-2008 | Current |
Kozhiparambath Anup | Director | 25-Jan-2008 | Current |
Financial Performance of Shoden Pharmaceuticals.
Enhance accessibility to Shoden Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Shoden Pharmaceuticals?
Unlock access to Shoden Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.90 M
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 0.09 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
16 Apr 2008 | Indian Bank | ₹0.90 M | Open |
How Many Employees Work at Shoden Pharmaceuticals?
Unlock and access historical data on people associated with Shoden Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shoden Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shoden Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.